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We and others have reported that glycogenin, the covalently bound protein found in muscle glycogen, also exists in muscle in a glycogen-free form 
(Mr 38 000-39 000) that is autocatalytic, undergoes elf-glucosylation and acts as a primer for glycogen synthesis. We now report that this entity 
is not present in a fresh muscle extract. Instead it exists within a pro form of much higher molecular mass which breaks down spontaneously to 
the M, 38 000-39 000 form. Such breakdown is accelerated by the addition of a-amylase and is prevented by protease inhibitors. Multiple inter- 
mediates of the breakdown process have been detected, each capable of undergoing lucosylation. 
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1. INTRODUCTION 
Glycogenin is the name we have given to a protein 
that is covalently linked to rabbit-muscle glycogen via 
the novel glucose-tyrosine bond [1,2]. A protein of 
similar M, (39 000) and free from glycogen is present in 
muscle and heart. It can be detected by its becoming 
glucosylated when tissue extracts are incubated with 2 
PM UDP[14C]glucose and 5 mM Mn2+ [3,4]. When 
purified to homogeneity the protein proved to contain 
a bound maltosaccharide residue and to be autocata- 
lytic, catalysing the addition of glucose to its bound 
maltosaccharide [5] and lengthening it to malto-octaose 
[6]. This product primes glycogen synthesis [5]. The 
purified protein (self-glucosylating protein; SGP) gives 
a positive immunoblot with antibody to glycogenin 
from muscle glycogen [5]. Glycogenin and SGP appear 
to be similar, if not identical, but we will use the 
separate names here to distinguish the origin of the pro- 
teins. 
Cohen and his collaborators found a glycogenin-like 
protein present in a muscle glycogen synthase prepara- 
tion in 1: 1 proportion with the synthase subunit (71. 
They confirmed the linkage of glycogen to tyrosine in 
glycogenin and showed that the protein complexed with 
synthase also contained glucose bound to tyrosine [8], 
further that this protein was also autocatalytic [9]. 
Campbell and Cohen [IO] have reported the complete 
amino acid sequence of glycogenin. 
We now report that SGP, although isolatable from 
muscle in a form having approximately the same M, as 
glycogenin from glycogen, does not seem to occur as 
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such in vivo. Rather, muscle contains a pro form of 
SGP, of much higher molecular weight. This form 
breaks down to SGP via intermediate forms when a 
muscle extract is incubated. 
2. MATERIALS AND METHODS 
2.1. Materials 
All biochemicals were from Sigma unless otherwise stated. 
UDP[%]glucose was from ICN Biochemicals. Acarbose was a gift 
from Dr E. Truscheit (Bayer AG, Wuppertal, FRG). ru-Amylase was 
prepared from human saliva asby Fischer and Stein [I 1] and was free 
from protease. 
2.2. Methods 
[‘4C]glucosylation of proteins in muscle extracts was carried out as 
by Lomako et al. [5], using 2pM UDP[‘4C]glucose and 5 mM MnClz 
in a 0.1 ml digest and incubating for 30 min at room temperature. A
50~1 portion was removed and added to 1 ml of 10% trichloroacetic 
acid (TCA) to precipitate protein which was filtered on a 
nitrocellulose HA filter, 0.45 PM, washed and the filter dried under 
an infrared lamp before the r4C was counted in scintillation liquid for 
nonaqueous amples. The remainder of the digest was freeze-dried 
and used for SDS-PAGE followed by radioautography with Kodak 
X-Omat XAR-5 film at -70°C and developing in an automated 
Kodak X-Omat film processor. Western blotting, with an antibody to 
rabbit-muscle glycogenin, was carried out as in [5]. 
For the preparation of extracts of skeletal muscle, a rabbit was 
sacrificed by injection of nembutal through the ear vein. The animal 
was desanguinated and the freshly removed muscle was freeze- 
clamped in small portions in liquid nitrogen and then stored at 
-75°C. Portions (l-3 g) were blended in a Potter Teflon 
homogenizer in 3 vols of extracting buffer [5] and centrifuged at 
16OOOxg for 15 min at 4°C. For the activation studies in Figs 1 and 
2 the supernatant was immediately assayed for protein glucosylation 
and then incubated at 37°C in the absence or presence of LY- 
glucosidase inhibitors (5 fig/ml). At intervals of 1 h a portion of each 
digest was incubated with UDP[‘4C]glucose as above and used to 
determine the degree of labelling of protein as well as for SDS-PAGE 
of the labelled proteins. 
For the study of protein glucosylation in gel-filtered extracts, a 
muscle extract prepared as above was precipitated by ammonium 
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sulfate at 50% saturation. After 1 h on ice the p&let was centrifuged 
as above, solubilized in 50 mM Tris-HCl buffer with 2 mM Chaps, pH 
7.4, and desalted on a Sephadex G-25 column (8 ml) which was wash- 
ed with the same buffer. The void volume was collected and used for 
the experiments shown in Fig. 3. The entire procedure from 
homogenizing the muscle to collecting the gel-filtered protein oc- 
cupied no more than 1.5 h. In Fig. 3, when salivary a-amylase was us- 
ed, it was in final concentrations of 0.95,4.75 and 19 fig/ml, respec- 
tively, in the experiments of lanes 1 l-13. When protein ghtcosylation 
was subsequently studied in these digests, acarbose (30 &ml) was 
added to inhibit the a-amylase. When proteolytic inhibitors were add- 
ed, these were as in the extracting buffer and at the same concentra- 
tions [5]. 
In order to test whether the ~‘4C]glucosylated proteins would act as 
primers for glycogen synthesis they were incubated with 2 PM 
UDPr’4C]glucose as above for 30 min and then freed from excess 
substrate by passing through Sephadex G-25. The void volume frac- 
tion was collected, unlabelled UDP-glucose to 5 mM and glucose 
6-phosphate to 9 mM were added and the digests were incubated for 
3 h at 37°C to allow endogeneous glycogen synthase and branching 
enzyme to utilize the [14C]glucosylated proteins as primers. The 
digests were then freeze-dried and subjected to SDS-PAGE, 
radioautography and Western blotting. 
The N-terminal sequencing of rabbit-muscle glycogen, prepared as 
by Kennedy et al. [I] and of SGP, prepared as by Lomako et al. [S], 
was attempted by Drs Keith Brew and Helmut E. Meyer, respectively. 
Both reported negative resuits that indicated a blocked N-terminus in 
each case. 
3. RESULTS AND DISCUSSION 
3.1. Detection of glucosyluted proteins of widely 
differing M, 
We were led to the conclusions reported here by the 
observation that SGP activity in a fresh muscle extract 
is relatively low and increases when the extract is stored. 
An incubation period of several hours at 37°C was 
necessary to develop full activity (Fig. 1). We have 
observed that ATP is a powerful allosteric inhibitor of 
SGP, such that at the physiological concentration of 
ATP, SGP activity in muscle is largely inhibited [12]. 
However, ATP disappears within a few minutes when 
muscle is minced yet the activation of SGP on incuba- 
tion of an extract was much slower (Fig. 1). 
SGP ‘activity’ is measured by allowing the protein to 
glucosylate itself fully. This is not a kinetic measure- 
ment but measures the total amount of glucose that can 
be incorporated. We reasoned that the increase in ex- 
tent of glucosylation seen on storing the extract might 
be the result of endpgenous a-glycosidase(s) (iu-amy- 
lase, cr-glucosidase) shortening the pre-existing malto- 
saccharide chains such that more glucose was now re- 
quired to lengthen them to malto-octaose [6], accoun- 
ting for the increased ‘activity’. 
Accordingly, we tested the effect of adding EY- 
glucosidase inhibitors to a muscle extract to learn 
whether activation was thereby prevented. Several in- 
hibitors were tested. Only one of them, acarbose, had 
any effect (Fig. 1). (Acarbose is also an a-amylase in- 
hibitor [13].) The effect of acarbose was, however, the 
opposite of that predicted. In its presence much more 
protein glucosylation occurred. 
Time of tuition (hr) 
Fig. 1. Showing the changes in the extents of protein giucosylation 
when a fresh unfiltered muscle extract is incubated in the absence and 
presence of acarbose (5 /rg/ml). A muscle extract (see section 2) was 
incubated at 37°C and assayed for protein glucosylation (see section 
2) at zero time and at intervals of 1 h. The experiment was also per- 
formed with added castanospermin, deoxynojirimycin and turanose 
(5 pg/ml each) but in these cases no differences from the control were 
seen. 
When we examined the ri4C]~ucosylated proteins by 
SDS-PAGE we observed that in the presence of acar- 
bose there was present a new series of labelled proteins 
with h&values between 50 000 and 80 000. Protein occu- 
pying the position of SGP was not seen (Fig. 2, lanes 
4,6). By contrast, these ‘acarbose’ proteins were absent 
from the acarbose-free xtract. Instead, two major pro- 
tein bands were seen (Fig. 2, lanes 3,5). That of lower 
M, corresponded to the SGP that we have purified to 
homogeneity. The other, with a somewhat greater M,, 
was more prominent. We will refer to it as ~42, its ap- 
proximate M,. 
All the labelled proteins gave positive immu~oblo~ 
with antibody to glycogenin from rabbit-muscle 
glycogen IS]. All acted as primers for glycogen syn- 
thase, since when incubated with unlabelled 5 mM 
UDP-glucose, all the r4C now moved to the top of the 
stacking gel, indicating its incorporation into glycogen- 
like material (results not shown). With the disap- 
pearance of the 14C bands from their original positions 
on the gel there was a corresponding disappearance of 
the immunoblot. One can examine protein glucosyla- 
tion in crude extracts without interference from the 
glycogen synthase present by using 2 ,.&I UDP- 
[r4C]glucose since the &, of SGP for UDP-glucose is 3 
orders of magnitude lower than that of glycogen syn- 
thase 151. Evidently this is also true for all the forms of 
labelled protein seen in Fig. 2. 
The relation between the various forms of glucosy- 
lated protein became clear when we decided to remove 
low molecular weight substances from a muscle extract 
by salt precipitation followed by passage through a 
molecular sieve (Sephadex G-25). The activation of pro- 
tein glucosylation previously seen only on incubating 
the muscle extracts (Fig. 1) now occurred immediately. 
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Fig. 2. Radioautograph of a fresh unfiltered muscle extract hat had 
been incubated without and with acarbose (5 rg/ml) as in Fig. 1, then 
incubated with 2/rM UDP[‘%]glucose and 5 mM Mn*+, freeze-dried, 
and subjected to SDS-PAGE. (Lane 1) t4C-labelled mol. wt. stan- 
dards; (lane 2), unincubated extract; (lane 3) extract after 3 h at 37°C; 
(lane 4) extract plus acarbose after 3 h at 37°C; (lanes 5 and 6) corres- 
pond respectively to lanes 3 and 4 for extracts that were stored for a 
further 4 days at 4°C. It is the lower of the two prominent bands in 
lanes 3 and 5 that corresponds to SGP [5] and the upper band that we 
refer to as ~42. 
Measured as in Fig. 1, the activity was 12000-14 000 
cpm, a 20-fold increase. Evidently there is a low 
molecular weight inhibitor of, or competitor for, pro- 
tein glucosylation in muscle and this is removed on 
G-25. The ‘activation’ phenomenon seen on incubation 
of an extract might instead represent he disappearance 
of the inhibitor/competitor. 
When the protein was glucosylated immediately after 
gel filtration of a fresh extract, and then subjected to 
SDS-PAGE, yet another pattern of glucosylation was 
seen (Fig. 3, lane 2). The radiolabelled protein now 
heardly penetrated the running gel and, very approx- 
imately, had M, 400 000 (~400). This occurred whether 
or not acarbose was present. It was after incubation of 
these filtered extracts that the patterns previously seen 
were restored (Fig. 2). If the extract was incubated 
without additives, breakdown with the formation of 
p42 and a barely visible amount of SGP occurred (lanes 
3,5) and the activity fell to 7500 cpm after 3 h. In the 
presence of acarbose, breakdown took place, but more 
slowly. The products had a higher M, than in the 
absence of acarbose and p42/SGP were absent (lanes 
7,9). The activity increased to 29000 cpm after 3 h. 
It is instructive also to compare lanes 2 in Figs 2 and 
3. Both refer to unincubated fresh muscle extracts. In 
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Fig. 3. A composite radioautograph showing the various forms of 
[‘4C]glucosylated protein dectected in rabbit muscle. Lane 1 is “‘C- 
labelled protein standards. A fresh muscle extract was salt 
precipitated and gel filtered as in section 2. This fraction was in- 
cubated with UDP[%]glucose and the freeze-dried igest was sub- 
jected to SDS-PAGE (lane 2). The experiments in all other lanes 
derive from the same fraction. After the specified pretreatment, all 
digests were incubated with UDP[r4C]glucose and freeze-dried before 
SDS-PAGE. (Portions of all these digests were also assayed for 14C- 
labelled, TCA-precipitable protein. Some of the results are quoted in 
the text.) Lanes 3 and 5, after prior incubation for 1 hand 3 h at 37”C, 
respectively. Lanes 4 and 6, as 3 and 5 but with added protease in- 
hibitors (see section 2). Lanes 7-10 correspond to lanes 3-6 except 
that acarbose (5 pg/ml) was added to the incubated fraction. Lanes 
11-13 represent he fraction of lane 2 incubated for 10 min at 37°C 
with increasing quantities of salivary cY-amylase (see section 2). The 
control for lanes 11-13, i.e. absence of cu-amylase, is not shown but 
was identical with lane 2. This figure is a composite photograph from 
four separate radioautographs (l-2, 3-6, 7-10, 11-13) lined up by 
means of the protein standards. 
Fig. 2, lane 2 no glucosylated protein is seen, cor- 
responding to the very small degree of protein glu- 
cosylation measured by scintillation counting (Fig. 1, 
zero time). By contrast, Fig. 3, lane 2 corresponds to 
the same extract as Fig. 2, lane 2, but this had been gel- 
filtered before incubation with UDP[14C]glucose. The 
~400 was now de-inhibited and could be glucosylated. 
A strong band of [‘4C]glucosylated protein is seen at the 
top of the gel. 
We deduce from the results seen in Figs 2 and 3 that 
the glucosylated species of M, approx. 40000 that we, 
Rodriguez and Fliesler [14] and Cohen et al. have 
previously reported as being involved in priming 
glycogen synthesis is not initially present in a muscle ex- 
tract. This seems clear from Fig. 3 in which only 
glucosylated protein of high A4, is seen in a fresh, gel- 
filtered muscle extract (lane 2). The products of lower 
M, are seen only when the extract is incubated under 
conditions that allow endogenous hydrolases to act on 
the high M, form. 
The high M, glucosylated protein is already familiar 
to us. We have reported elsewhere that differentiated 
adipocytes and a rat mammary adenocarcinoma each 
contain a protein (or proteins) of Mr about 400000, 
similar to that now seen in muscle 1151. Like muscle 
SGP, the M, 400000 protein already contains bound 
carbohydrate and undergoes glucosylation under the 
10 
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same conditions as SGP, forming maltosaccharide 
chains up to DP 14 [ 151. This was seen in unfiltered ex- 
tracts. Evidently there is no (or less) low-molecular- 
weight inhibitor of protein glucosylation in the adi- 
pocyte or adenocarcinoma than in muscle, and less of 
the enzyme(s) that convert ~400 into smaller products. 
3.2. The nature of the glycogen primer 
We are presented with an apparent paradox in that 
the protein in muscle glycogen is the M, 37000 gly- 
cogenin [ 11. A glycogen-free, self-glucosylating protein 
(SGP), seemingly identical, is present in muscle and acts 
as a primer for glycogen synthesis in vitro [5,9]. But 
now it appears that the latter is a breakdown product of 
a much higher molecular weight species (~400). What is 
the structural relation between ~400, SGP and gly- 
cogenin from glycogen? 
The answer to this question was partly revealed as the 
result of attempts to accelerate or arrest the breakdown 
of ~400. We decided to fortify the gel-filtered muscle 
extract with cu-amylase, or trypsin or proteolytic in- 
hibitors and learn the results of incubation. The pro- 
tease inhibitors were the same as we use when extracting 
muscle to prepare SGP [5] but which are removed in 
subsequent steps, as there were here, by salt precipita- 
tion and gel filtration. a-Amylase had a dramatic ef- 
fect, rapidly causing the formation of p42 and SGP 
with the former predominating at the lower concentra- 
tion of enzyme and the latter at the higher concentra- 
tion (Fig. 3, lanes 11-13). Therefore, we might con- 
clude that ~400 is simply SGP protein (glycogenin) car- 
rying a large amount of glycogen-like carbohydrate. 
The addition of trypsin (results not shown) did not 
materially change the pattern of conversion of ~400 in- 
to p42/SGP, except hat at a high trypsin concentration 
protein glycosylation was not seen. 
The addition of protease inhibitors, however, essen- 
tially blocked the breakdown of ~400 (Fig. 3, lanes 
4,6,8,10), and the activity was practically unchanged at 
about 10000 cpm during 3 h of incubation whether 
acarbose was absent (lanes 4,6) or present (lanes 8,lO). 
Therefore we must conclude that not only amylolysis 
but also proteolysis is necessary to cause the breakdown 
of ~400, i.e. ~400 contains more carbohydrate and 
more protein than does p42 or SGP. The latter conclu- 
sion depends for its validity on the specificity of the 
protease inhibitors only to inhibit proteases. The effect 
of acarbose in arresting the breakdown of ~400 at an in- 
termediate step (Fig. 2) suggests that at least two en- 
dogenous glycosidases are involved in the conversion 
seen in vitro and that acarbose inhibits one of them. 
We also tested the effect of a-amylase on a filtered 
extract in the presence of protease inhibitors. The 
results were similar to those seen in the absence of the 
inhibitors (Fig. 3, lanes ll-13), except hat at the lowest 
concentration of cu-amylase (0.95 pg/ml) the gluco- 
sylating activity fell in lo-30 min to less than 10% of 
the original (it fell to 40% without protease inhibitors) 
and no [ 14C]glucosylated protein could be seen by SDS- 
PAGE until after 2-3 h, by which time the activity had 
increased to 20% of the original and bands were seen in 
the region M, 50000-80 000. At the higher cu-amylase 
concentrations, glucosylated proteins with M, values 
near to SGP and p42 were seen at all times and the 
glucosylating activity fell to and remained at about 20% 
of the original. 
We now intend to learn the structure of ~400. In 
terms of protein content, a clue comes from the report 
by Campbell and Cohen [lo] that glycogenin from mus- 
cle glycogen has a blocked N-terminus. We can now 
report the same observation and, in addition, that SGP 
also has a blocked N-terminus. Therefore, if ~400 con- 
tains a larger protein moiety than SGP the extension is 
likely to be at the C-terminus. 
Recognizing that p42 is a species distinct from SGP 
we have looked for both forms during the purification 
of SGP and find that both co-purify and are separated 
only in the final HPLC purification step 151. By this 
means we obtained homogeneous p42 and, in an experi- 
ment not shown, could convert it into a species having 
the same A4, as SGP with the use of cu-amylase, similar 
to the disappearance of p42 and the appearance of SGP 
seen in the gel-filtered muscle extract when cw-amylase 
was added (Fig. 3, lanes 11-13). It seems that in the 
vicinity of the protein the last few residues of car- 
bohydrate are less easily removed. (The homogeneous 
p42 underwent glucosylation when incubated with 
UDP-glucose and therefore can also be assumed to be 
autocatalytic.) 
Our conclusions regarding the nature of the primer 
for glycogen synthesis need to be revised. What we have 
now detected in muscle in the form of ~400 is a quite 
different glycoprotein than has previously been describ- 
ed. It appears to have a somewhat larger protein moeity 
and a much higher content of carbohydrate. SGP, in 
the form that we have previously isolated it, results 
from the breakdown of ~400 during the purification 
process. We have still not detected a carbohydrate-free 
species of SGP, nor do we know how the initial glu- 
cosylation of the protein occurs, only that as isolated, in 
the form of SGP, the protein is autocatalytic and adds 
further glucose to itself. How such glucosylation par- 
ticipates in the formation of ~400 remains to be elu- 
cidated. 
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